Valneva SE (VALN) EPS (Basic) (2021 - 2026)

Valneva SE (VALN) reported EPS (Basic) of -$0.16 for Q1 2026, down 283.38% on a YoY basis from $0.09 in Q1 2025, and up 52.41% sequentially from -$0.35 in Q4 2025.

Valneva SE (VALN) EPS (Basic) (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has 6 years of EPS (Basic) data on file, last reported at -$0.16 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) fell 283.38% year-over-year to -$0.16; the trailing twelve-month figure through Mar 2026 stood at -$0.84 (down 87.58% YoY), and the FY2025 full-year result was -$0.8, down 905.39% from the prior year.
  • EPS (Basic) improved to -$0.16 in Q1 2026, from -$0.35 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.53 in Q1 2024 to a low of -$0.5 in Q4 2022.
  • A 5-year average of -$0.12 and a median of -$0.15 in 2023 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) tumbled 123615.07% in 2023 and soared 446.97% in 2024, its largest moves.
  • Tracing VALN's EPS (Basic) over 5 years: stood at -$0.5 in 2022, then jumped by 61.17% to -$0.19 in 2023, then gained by 20.77% to -$0.15 in 2024, then plunged by 126.31% to -$0.35 in 2025, then soared by 52.41% to -$0.16 in 2026.
  • Business Quant data shows VALN's EPS (Basic) at -$0.16 in Q1 2026, -$0.35 in Q4 2025, and -$0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Valneva SE 811.46 Mn 688.23 Mn 5.08 Mn -0.16

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.16
Dec 31, 2025 -0.35
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 -0.04
Dec 31, 2024 -0.15
Sep 30, 2024 -0.10
Jun 30, 2024 -0.17
Mar 31, 2024 0.53
Dec 31, 2023 -0.19
Sep 30, 2023 -0.21
Jun 30, 2023 -0.17
Mar 31, 2023 -0.15
Dec 31, 2022 -0.50
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 -0.29
Dec 31, 2021 1.98
Sep 30, 2021 -2.05
Jun 30, 2021 -0.75